Spanish Registry of Esophagogastric Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorFundación Sociedad Española de Oncologia Médica
About this trial
This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.
Eligibility criteria
Qualifiers
Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).
Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.
Disqualifiers
A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.
Trial design
Treatments tested in this trial
- Surgery
- Chemotherapy, anti-targeted agents and immunotherapy
- Radiotherapy
Treatment groups
10,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov